Artwork

Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Newer NNRTI Agents in Clinical Practice

27:40
 
Distribuie
 

Manage episode 371092380 series 2065653
Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine appears to provide a favorable impact on weight and lipid outcomes, but with a lower genetic barrier to resistance. Which patients is it right for and in which ones should it be avoided?

Join us as we discuss Newer NNRTI Agents in Clinical Practice with Dr. Darcy Wooten from the Division of Infectious Disease at the University of California, San Diego, in this issue of eHIV Review.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoade

Artwork

Newer NNRTI Agents in Clinical Practice

DKBmed Radio

19 subscribers

published

iconDistribuie
 
Manage episode 371092380 series 2065653
Content provided by DKBmed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DKBmed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.

Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine appears to provide a favorable impact on weight and lipid outcomes, but with a lower genetic barrier to resistance. Which patients is it right for and in which ones should it be avoided?

Join us as we discuss Newer NNRTI Agents in Clinical Practice with Dr. Darcy Wooten from the Division of Infectious Disease at the University of California, San Diego, in this issue of eHIV Review.


Take our post-test to claim CME credits.

To read a companion newsletter click here.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

214 episoade

모든 에피소드

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință